“Two-phase”的搜索结果，显示 101-110 项，共有 7503 项

1. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   ... two future steps: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

3. 血液科- 临床试验- 妙佑医疗国际

   This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken with Q901 at the RP2D administered in combination with pembrolizumab (400 mg Q6W) ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

7. 血液科- 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

8. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...